propafenone hydrochloride (Glenmark Pharmaceuticals Inc., USA)
Welcome to the PulseAid listing for the propafenone hydrochloride drug offered from Glenmark Pharmaceuticals Inc., USA. This Antiarrhythmic [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Glenmark Pharmaceuticals Inc., USA |
| NON-PROPRIETARY NAME: | propafenone hydrochloride |
| SUBSTANCE NAME: | PROPAFENONE HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Antiarrhythmic [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE, EXTENDED RELEASE |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2017-09-08 |
| END MARKETING DATE: | 0000-00-00 |
propafenone hydrochloride HUMAN PRESCRIPTION DRUG Details:
| Item Description | propafenone hydrochloride from Glenmark Pharmaceuticals Inc., USA |
| LABELER NAME: | Glenmark Pharmaceuticals Inc., USA |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 225(mg/1) |
| START MARKETING DATE: | 2017-09-08 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 68462-408_c6890ed8-ef11-4889-aa53-a4bc9da16653 |
| PRODUCT NDC: | 68462-408 |
| APPLICATION NUMBER: | ANDA205268 |
Other PROPAFENONE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
